About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Anxiety Clinical Trials in Chicago | 15 Studies

Clinical Trials AnxietyChicago

Anxiety Clinical Trials in Chicago

Find 15 clinical trials for anxiety near Chicago, Illinois. Connect with research centers in your area.

All Anxiety trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-15 of 15 trials

WithdrawnMobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to MenThe purpose of this study is to determine whether a mobile phone application ("app") for symptoms of depression and anxiety is practical and acceptable to young men who are…NCT02072252·Chicago, Illinois WithdrawnA Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs AloneGeneralized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD.NCT04965272·Little Rock, Arkansas and 35 others

Anxiety Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety DisorderA clinical study that will meaure how well SEP-363856 works and how safe it is in adults with Generalized Anixety Disorder.NCT05729373·Huntsville, Alabama and 82 others

Active not recruitingA Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized Anxiety Disorder - VoyageNCT06741228·Gilbert, Arizona and 33 others

RecruitingStudy to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderGeneralized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD.NCT06846320·Huntsville, Alabama and 51 others

Active not recruitingPartners in Caring for Anxious YouthPediatric onset anxiety disorders (generalized anxiety, social anxiety, separation anxiety) are highly prevalent, and if untreated, are impairing into adolescence and adulthood.NCT04598230·Los Angeles, California and 2 others

TerminatedPOC Study in Partially Responsive Generalized Anxiety DisorderThis study aims to evaluate whether PF-06372865 is safe and effective in the treatment of sub-optimally controlled symptoms of generalized anxiety disorder during two 4-week…NCT02310568·Cerritos, California and 46 others

CompletedStudy of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderThe purpose of this study is to evaluate the safety and efficacy of 2.5 mg and 10 mg vortioxetine, once daily (QD), in adults with generalized anxiety disorder.NCT00731120·Birmingham, Alabama and 39 others

CompletedA Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsThis is a Phase 2, multi-center, randomized, double-blind, parallel-group, dose-finding study to assess the effect of 4 doses of MM120 (25, 50, 100 or 200 μg freebase-equivalent)…NCT05407064·Little Rock, Arkansas and 21 others

RecruitingRE104 Safety and Efficacy Study in Generalized Anxiety DisorderThe purpose of this study is to determine if treatment with a single and/or repeat dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety…NCT07489651·Birmingham, Alabama and 27 others

CompletedSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety DisorderThe purpose of this study is to demonstrate that quetiapine SR (SEROQUEL®) is efficacious and safe in the acute treatment of patients with Generalized Anxiety Disorder.NCT00329264·Springdale, Arizona and 57 others

CompletedA Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)The purpose of this proof-of-concept trial is to examine the safety, tolerability, and pharmacokinetics (PK), and preliminary clinical efficacy of CYB004 participants with GAD.NCT06051721·Hollywood, Florida and 5 others

CompletedGeneralized Anxiety Disorder Adjunct StudyThis study is being carried out to see if extended release quetiapine fumarate (Seroquel®XL) when added to standard selective serotonin reuptake inhibitor (SSRI) /…NCT00534599·Birmingham, Alabama and 52 others

RecruitingDevice for Treating Generalized AnxietyThe goal of this clinical trial is to learn if treatment with the BTL-699-2 device (non-invasive repetitive transcranial magnetic stimulation) can decrease anxiety symptoms in…NCT07819773·Denver, Colorado and 2 others

CompletedSafety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety DisorderThe purpose of this study is to evaluate the efficacy, safety and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD)NCT01629966·Birmingham, Alabama and 36 others

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia